These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33627403)

  • 1. Mitochondrial hydrogen sulfide supplementation improves health in the
    Ellwood RA; Hewitt JE; Torregrossa R; Philp AM; Hardee JP; Hughes S; van de Klashorst D; Gharahdaghi N; Anupom T; Slade L; Deane CS; Cooke M; Etheridge T; Piasecki M; Antebi A; Lynch GS; Philp A; Vanapalli SA; Whiteman M; Szewczyk NJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
    Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
    Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of striated muscle degeneration by serotonin in C. elegans.
    Carre-Pierrat M; Mariol MC; Chambonnier L; Laugraud A; Heskia F; Giacomotto J; Ségalat L
    J Muscle Res Cell Motil; 2006; 27(3-4):253-8. PubMed ID: 16791712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
    van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
    FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
    Timpani CA; Goodman CA; Stathis CG; White JD; Mamchaoui K; Butler-Browne G; Gueven N; Hayes A; Rybalka E
    Sci Rep; 2020 Jan; 10(1):1125. PubMed ID: 31980663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
    Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
    PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome changes during the initiation and progression of Duchenne muscular dystrophy in Caenorhabditis elegans.
    Hrach HC; O'Brien S; Steber HS; Newbern J; Rawls A; Mangone M
    Hum Mol Genet; 2020 Jun; 29(10):1607-1623. PubMed ID: 32227114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    FEBS Lett; 2018 Jun; 592(11):1856-1869. PubMed ID: 29772070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
    Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.
    Giacomotto J; Brouilly N; Walter L; Mariol MC; Berger J; Ségalat L; Becker TS; Currie PD; Gieseler K
    Hum Mol Genet; 2013 Nov; 22(22):4562-78. PubMed ID: 23804750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
    Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
    J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of
    Hewitt JE; Pollard AK; Lesanpezeshki L; Deane CS; Gaffney CJ; Etheridge T; Szewczyk NJ; Vanapalli SA
    Dis Model Mech; 2018 Dec; 11(12):. PubMed ID: 30396907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.